Skip to content

Single blinded study for the evaluation of bitterness of quinine hydrochloride and loperamide hydrochloride in healthy adult female and male volunteers

Single blinded study for the evaluation of bitterness of quinine hydrochloride and loperamide hydrochloride in healthy adult female and male volunteers - Study of the evaluation of bitter taste

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000021789
Enrollment
10
Registered
2016-04-05
Start date
2016-04-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All of diseases that oral medication is prescribed

Interventions

All the volunteers will taste 9 and 7 samples including water in order to investigate the threshold concentration of quinine hydrochloride and loperamide hydrochloride for the recognition of bitternes

Sponsors

Intelligent Sensor Technology, Inc.
Lead Sponsor
Medical and Health Resources Research Institute
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy female and male adult

Exclusion criteria

Exclusion criteria: 1. People who are not like degustation 2. People who are allergic to drugs (quinine hydrochloride, loperamide hydrochloride) 3. people not eligible by the discretion of the investigator

Design outcomes

Primary

MeasureTime frame
A filter paper wetted with bitter substance will be placed on the tongue of volunteers and the strength of bitterness will be measured within 1 minute. After rinsing thoroughly in the mouth with water, then strengths of bitterness of quinine hydrochloride and loperamide hydrochloride will be measured.

Secondary

MeasureTime frame
In each volunteer, the concentration of loperamide hydrochloride which produces the same bitterness of quinine hydrochloride at 30 times higher concentration of the threshold value.

Countries

Japan

Contacts

Public ContactJun Kojima, PhD.

Medical and Health Resources Research Institute No

kojima@mhrri.com03(5904)8534

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026